Life Sciences

Accelerate Drug Development and Deliver Real World Evidence of Therapy Response

Contact Us

Leverage Radiomics to Uncover the Data Story Behind the Image

In today’s vast healthcare data environment over 90% of data resides in medical imaging. Yet there remains an ongoing industry challenge because 97% of this data goes unused or unanalyzed. Clinicians and researchers are flying blind with an absence of critical imaging data to inform clinical trial support, therapy management, and value-based clinical outcomes.

But there is an answer.

At HealthMyne, we are pioneers in applied radiomics, the cutting-edge field of extracting novel data and biomarkers from medical images. We help life science organizations like yours access and easily translate ground-breaking radiomic insights into use in research, commercial strategies, and personalized health agendas.

Radiomics is the next wave in healthcare, unleashing the hidden power of imaging data to speed drug and treatment development and the achievement of personalized medicine.

Maximize the Power of Your Imaging Data

previous arrow
Curate Imaging Data Pipeline

Curate Imaging Data Pipeline

  1. Aggregate and manage multi-modal imaging data
  2. Minimize variation across readers
  3. Reveal “below the surface” radiomic insights
  4. Capture imaging derived phenotypes (IDPs)
  5. Identify metrics for use in drug development and trials management pipeline
Discover and Leverage Imaging Biomarkers

Discover and Leverage Imaging Biomarkers

  1. Inform and manage patient recruitment and cohort design
  2. Leverage in study design, inclusion criteria, and stratification
  3. Inform drug phase advancement and trial end points
  4. Develop predictive and prognostic capacity
Enhance and Expand Existing Clinical Trials

Enhance and Expand Existing Clinical Trials

  1. Incorporate radiomic insights in inclusion criteria and study design
  2. Leverage more precise and diverse endpoints for improved outcomes
  3. Measure radiomic data and response to therapy over time
  4. Support adaptive trial design
Drive Value-based Clinical Outcomes

Drive Value-based Clinical Outcomes

  1. Correlate clinical value and improved patient outcomes with therapy
  2. Transparency into patient population that will benefit from drug
  3. Support value-based contracting and reimbursement strategies
  4. Leverage to inform payment policy decisions
  5. Navigate payer conversations and negotiation
Predict Response Earlier in Care Journey

Predict Response Earlier in Care Journey

  1. Inform treatment journey through use of imaging biomarkers
  2. Leverage predictive and prognostic indicators of patient outcomes in treatment planning
  3. Inform real-world evidence
  4. Improve standard of care based on proven outcomes
Analyze Real-World Evidence of Therapy Response

Analyze Real-World Evidence of Therapy Response

  1. Inform patient stratification and trial arm assignment
  2. Improve patient retention on protocols
  3. Potential to increase trial availability
  4. Incorporate and automate trial protocol and reporting requirements
next arrow

Radiomic Solutions for Life Sciences

Our innovative AI and radiomic informed solutions can help your organization curate and digitize data from medical images as well as extract radiomic features to accelerate drug development and deliver real world evidence of therapy response. In addition, radiomic data can enhance and expand existing clinical trials and deliver precise endpoints to inform trial design, inclusion criteria and trial cohorts.

Learn more about HealthMyne’s® Radiomic Precision Metrics (RPM) and Radiomic Discovery Services

HealthMyne provides radiomic-informed workflow tools for documenting therapy and treatment response, ensuring appropriate clinical protocol assignment, and efficiently tracking patients through the trial process.

Learn more about HealthMyne’s Radiomic Informed Therapy Response Module